medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2018-15-38-42medsovet-2669Research ArticleБронхиальная астмаBronchial asthmaЛегкая бронхиальная астма: от парадоксов к оптимизации терапииMild asthma: from paradoxes to therapy optimizationФассаховР. С.FassakhovR. S.

Фассахов Рустем Салахович – доктор медицинских наук, профессор, кафедра фундаментальных основ клинической медицины Института фундаментальной медицины и биологии

Институт фундаментальной медицины и биологии Казанского (Приволжского) федерального университетаРоссияInstitute of Fundamental Medicine and Biology; Kazan (Volga Region) Federal UniversityRussian Federation2018111020180153842Copyright © Фассахов Р.С., 20182018Фассахов Р.С.Fassakhov R.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/2669

Обострения бронхиальной астмы характерны не только для тяжелого, но и для легкого течения заболевания. Анализ причин выявил парадоксы в лечении, которые способствуют неконтролируемому течению легкой астмы. Перспективным направлением является использование комбинированных препаратов, содержащих в составе быстродействующий бета-2агонист и ингаляционный глюкокортикостероид, позволяющие значимо повысить приверженность лечению, существенно улучшить контроль и снизить количество обострений. В обзоре детально обсуждаются достоинства комбинированного препарата СабаКомб, его место в рекомендациях по лечению легкой бронхиальной астмы.

Exacerbations of bronchial asthma are specific not only for severe, but also for mild disease course. Analysis of the causes revealed paradoxes in the treatment that contribute to the uncontrolled course of mild asthma. A promising direction is the use of combination drugs containing a early-onset beta-2-agonist and inhaled glucocorticosteroid, which can significantly improve adherence to treatment and significantly improve control and reduce the number of exacerbations. The review discusses in detail the merits of the combination drug SabaComb, its place in the recommendations for the treatment of mild asthma.

легкая астмаконтроль астмыприверженность терапииСабаКомбmild asthmaasthma controladherence to treatmentSabaComb.ReferencesNunes C et al. Asthma costs and social impact. Asthma Res Pract, 2017, 3: 1.Nunes C et al. Asthma costs and social impact. Asthma Res Pract, 2017, 3: 1.Chastek B et al. Economic Burden of Illness Among Patients with Severe Asthma in a Managed Care Setting. J Manag Care Spec Pharm, 2016, 22(7): 848-861.Chastek B et al. Economic Burden of Illness Among Patients with Severe Asthma in a Managed Care Setting. J Manag Care Spec Pharm, 2016, 22(7): 848-861.Global Initiative for Asthma. 2018 GINA Report, Global Strategy for Asthma Management and Prevention.Global Initiative for Asthma. 2018 GINA Report, Global Strategy for Asthma Management and Prevention.Rabe KF, Vermeire PA, Soriano JB et al. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) stud. Eur Respir J, 2000, 16: 802–807.Rabe KF, Vermeire PA, Soriano JB et al. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) stud. Eur Respir J, 2000, 16: 802–807.Sadatsafavi M, Lynd L, Marra C et al. Direct health care costs associated with asthma in British Columbia. Can Respir J, 2010, 17(2): 74–80.Sadatsafavi M, Lynd L, Marra C et al. Direct health care costs associated with asthma in British Columbia. Can Respir J, 2010, 17(2): 74–80.Com-Ruelle L, Crestin B, Dumesnil SL. Asthmeen France selon les stades. La Lettre du Pneumologue, 2000, III(5): 191–193.Com-Ruelle L, Crestin B, Dumesnil SL. Asthmeen France selon les stades. La Lettre du Pneumologue, 2000, III(5): 191–193.Ненашева Н.М., Буриев Б.Б. Особенности атопической бронхиальной астмы у взрослых. Российский аллергологический журнал, 2009, 4: 12–17.Nenasheva NM, Buriev BB. Features of atopic asthma in adults. Rossiyskiy Allergologicheskiy Zhurnal, 2009, 4: 12–17.Архипов В.В., Григорьева Е.В., Гавришина Е.В. Контроль над бронхиальной астмой в России: результаты многоцентрового наблюдательного исследования НИКА. Пульмонология, 2011, 6: 80–86.Arkhipov VV, Grigorieva EV, Gavrishina EV. Asthma control in Russia: results of the multicenter observational NIKA study. Pulmonologiya, 2011, 6: 80–86Robertson CF, Rubinfield AR, Bowes G. Pediatriccasthmadeaths in Victoria: the mild are at risk. Pediatr Pulmonol, 1992, 13(2): 95–100.Robertson CF, Rubinfield AR, Bowes G. Pediatriccasthmadeaths in Victoria: the mild are at risk. Pediatr Pulmonol, 1992, 13(2): 95–100.Salmeron S, Liard R, Elkharrat D, Muir J, Neukirch F, Ellrodt A. Asthma severity and adequacy of management in accident and emergency departments in France: a prospective study. Lancet, 2001, 358: 629–635.Salmeron S, Liard R, Elkharrat D, Muir J, Neukirch F, Ellrodt A. Asthma severity and adequacy of management in accident and emergency departments in France: a prospective study. Lancet, 2001, 358: 629–635.Mitchell I, Tough SC, SempleLK,Green FH, Hessel PA. Near-fatal asthma:a populationbased study of riskfactors. Chest, 2002, 121: 1407–1413.Mitchell I, Tough SC, SempleLK,Green FH, Hessel PA. Near-fatal asthma:a populationbased study of riskfactors. Chest, 2002, 121: 1407–1413.Why Asthma still kills. The National Review of Asthma Deaths. 2014. www.rcpiondon.ac.uk.Why Asthma still kills. The National Review of Asthma Deaths. 2014. www.rcpiondon.ac.uk.Yang JF et al. Insights into frequent asthma exacerbations from a primarycare perspective and the implications of UK National Review of Asthma Deaths recommendations. NPJ Primary Care Respiratory Medicine, 2018, 28: 35.Yang JF et al. Insights into frequent asthma exacerbations from a primarycare perspective and the implications of UK National Review of Asthma Deaths recommendations. NPJ Primary Care Respiratory Medicine, 2018, 28: 35.Boushey HA, Sorkness CA, King TS et al. Daily versus As-Needed Corticosteroids for Mild Persistent Asthma. N Engl J Med, 2005, 352: 1519–1528.Boushey HA, Sorkness CA, King TS et al. Daily versus As-Needed Corticosteroids for Mild Persistent Asthma. N Engl J Med, 2005, 352: 1519–1528.O’Byrne PM, Jenkins C, Bateman ED. The paradoxes of asthma management: time for a new approach? Eur Respir J, 2017, 50: 1701103.O’Byrne PM, Jenkins C, Bateman ED. The paradoxes of asthma management: time for a new approach? Eur Respir J, 2017, 50: 1701103.World Health Organization. Adherence to longterm therapies: Evidence for action. Geneva, WHO, 2003.World Health Organization. Adherence to longterm therapies: Evidence for action. Geneva, WHO, 2003.Williams LK, Pladevall M, Xi H et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol, 2004, 114: 1288–1293.Williams LK, Pladevall M, Xi H et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol, 2004, 114: 1288–1293.Laforest L, Licaj I, Devouassoux G et al. Prescribed therapy for asthma: therapeutic ratios and outcomes. BMC Fam Pract, 2015, 16: 49.Laforest L, Licaj I, Devouassoux G et al. Prescribed therapy for asthma: therapeutic ratios and outcomes. BMC Fam Pract, 2015, 16: 49.Papi A, Canonica GW, Maestrelli P et al. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. N Engl J Med, 2007, 356(20): 2040–2052.Papi A, Canonica GW, Maestrelli P et al. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. N Engl J Med, 2007, 356(20): 2040–2052.Fredenburgh L, Campion E, Drazen JM. Mild Persistent Asthma – Polling Results. N Engl J Med, 2007, 357: 179–180.Fredenburgh L, Campion E, Drazen JM. Mild Persistent Asthma – Polling Results. N Engl J Med, 2007, 357: 179–180.Martinez FD, Chinchilli VM, Morgan WJ et al Use of beclomethasone dipropionate as rescue treatment for childrenwith mild persistent asthma (TREXA): a randomised, doubleblind,placebo-controlled trial. Lancet, 2011, 377: 650-657.Martinez FD, Chinchilli VM, Morgan WJ et al Use of beclomethasone dipropionate as rescue treatment for childrenwith mild persistent asthma (TREXA): a randomised, doubleblind,placebo-controlled trial. Lancet, 2011, 377: 650-657.Авдеев С.Н. с соавт. Принципы выбора терапии для больных легкой бронхиальной астмой. Согласованные рекомендации РААКИ и РРО. Практическая пульмонология, 2017, 1: 82-92.Avdeev SN, et al. Principles of choice of therapy for patients with mild bronchial asthma. Concerted guidelines of Russian Association of Allergologists and Clinical Immunologists and Russian Respiratory Society. Prakticheskaya Pulmonologiya, 2017, 1: 82-92.

The authors declare that there are no conflicts of interest present.